Why some patients don't respond to GLP-1 drugs: scientists seek answers

GLP-1 drugs like semaglutide are hailed as a breakthrough in obesity treatment, yet some patients experience no weight loss from them. Researchers are intensively investigating the causes of this variability, hoping results will enable new therapies and personalized weight loss plans. The findings were published in Nature.